Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Histone Lysine Methyltransferases MLL3 and MLL4 Direct Gene Expression To Produce Platelets Efficiently, Guozhen Gao, Josimar Dornelas Moreira, Prosun Das, et al.
Detection of the Linac Jaw Face Angle Misalignment Using High Energy Electron Beam Symmetry, Song Gao, Andres Cibrian, Jared Ohrt, et al.
Caloric Restriction and Telomere Preservation in TERT Knockout Adipocyte Progenitors Does Not Rescue Mice From Metabolic Dysfunction due to a TERT Function in Adipocyte Mitochondria., Zhanguo Gao, Yongmei Yu, Kristin Eckel-Mahan, et al.
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes, Jacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, et al.
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes, Jacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, et al.
Understanding Infectious Complications in Patients With Lower-Risk Myelodysplastic Syndromes: A Step Towards Improving Survival, Guillermo Garcia-Manero
A Phase 1 Study of Durvalumab As Monotherapy or Combined With Tremelimumab With or Without Azacitidine in Patients With Myelodysplastic Syndrome, Guillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.
A Plain Language Summary of the ASCERTAIN Trial: Oral Decitabine and Cedazuridine Versus Intravenous Decitabine for MDS or CMML, Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, et al.
Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial, Guillermo Garcia-Manero, Valeria Santini, Amer M Zeidan, et al.
Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular Subtypes, Carl M Gay, Taofeek K Owonikoko, Lauren A Byers, et al.
Intentional Creation of Suboptimal, Realistic Dose Distributions, Skylar S Gay, Mary P Gronberg, Raymond Mumme, et al.
Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321, James I Geller, Lindsay A Renfro, Paul E Grundy, et al.
Rare Damaging CCR2 Variants Are Associated With Lower Lifetime Cardiovascular Risk, Marios K Georgakis, Rainer Malik, Omar El Bounkari, et al.
Association Between B-Cell Marker Expression and RUNX1 Lesions in Acute Myeloid Leukemia, Beyond RUNX1::RUNX1T1 Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia—B/Myeloid, Giby V George, Malgorzata Kajstura, Audrey N Jajosky, et al.
Obesity Predisposes Anthracycline-Treated Survivors of Childhood and Adolescent Cancers to Subclinical Cardiac Dysfunction, Ian A George, BriAnna Souder, Amy Berkman, et al.
Systematic Literature Review of Intravenous Versus Subcutaneous Administration of Oncology Therapies: A Clinical, Economic and Patient Perspective, Saby George, Maria T Bourlon, Michael J Overman, et al.
Long-Term Patient-Reported Bowel and Urinary Quality of Life in Patients Treated with Intensity-Modulated Radiotherapy Versus Intensity-Modulated Proton Therapy for Localized Prostate Cancer, Kimberly R Gergelis, Miao Bai, Jiasen Ma, et al.
Dosimetric Advantage of Scanning Beam Proton Therapy in Gynecologic Patients Receiving Adjuvant Radiotherapy, Rachel B Ger, Jarrod M Lentz, Joshua S Niedzielski, et al.
A Novel Sensitivity Maximization at a Given Specificity Method for Binary Classifications, Seyyed Mahmood Ghasemi, Chunhui Gu, Johannes F Fahrmann, et al.
Targeted Inhibition of Aurora Kinase a Promotes Immune Checkpoint Inhibition Efficacy in Human Papillomavirus-Driven Cancers, Soma Ghosh, Madison P O'Hara, Pragya Sinha, et al.
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease, Claudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
DNA Methylation Cooperates With Genomic Alterations During Non-Small Cell Lung Cancer Evolution, Francisco Gimeno-Valiente, Carla Castignani, Elizabeth Larose Cadieux, et al.
canSAR 2024-An Update to the Public Drug Discovery Knowledgebase, Phillip W Gingrich, Rezvan Chitsazi, Ansuman Biswas, et al.
TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature, Madison P Ginn, Ryan A Denu, Davis R Ingram, et al.
A Sample Size Analysis of a Mathematical Model of Longitudinal Tumor Volume and Progression-Free Survival for Bayesian Individual Dynamic Predictions in Recurrent High-Grade Glioma, Daniel J Glazar, Solmaz Sahebjam, Hsiang-Husan M Yu, et al.